SCHEMBL15315526

SCHEMBL15315526

c1cc(-c2cccc(-c3cccc(-c4cccc(-c5ccc6c(c5)sc5ccccc56)c4)c3)c2)cc(-c2cccc(-c3cccc(-c4ccc5c(c4)sc4ccccc45)c3)c2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.58
ALDH1A1 P00352 5/20 0.57
MAPT P10636 3/20 0.57
HPGD P15428 2/20 0.57
RAB9A P51151 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
ALOX5 P09917 1/20 0.44
LIMK1 P53667 4/20 0.41
TNKS O95271 1/20 0.40
TNKS2 Q9H2K2 1/20 0.40
POLB P06746 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
F9 P00740 1/20 0.40
ALOX15 P16050 2/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15315522 1.00 GPR3 (0.58) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL15315516 1.00 GPR3 (0.58) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL15315519 1.00 GPR3 (0.58) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL15315586 0.98 GPR3 (0.56) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL15315585 0.98 GPR3 (0.56) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL15315517 0.98 GPR3 (0.56) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL15315583 0.98 GPR3 (0.56) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL15315515 0.98 GPR3 (0.56) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL15315580 0.98 GPR3 (0.56) GPR3ALDH1A1MAPTHPGDRAB9A
SCHEMBL15315523 0.98 GPR3 (0.56) GPR3ALDH1A1MAPTHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10944061-B2 Organic electroluminescent element and compound UDC IRELAND LIMITED (IE) 2021-03-09 US disclosed
US-20130270530-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND UDC IRELAND LIMITED (IE) 2013-10-17 US disclosed
US-20130270530-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND UDC IRELAND LIMITED (IE) 2013-10-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10944061-B2 Organic electroluminescent element and compound POU2F2, DDT, LEF1 GPR3 4533/4885ALDH1A1 1094/4885MAPT 713/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.